supplemental materials

This study investigates the additional impact of Leap Motion-based VR therapy, when used alongside conventional treatment, on the upper extremity function, physical activity and participation of stroke patients. Forty post-stroke patients were randomly assigned to either a control (CG) or an experimental group (EG). Both groups received 60 minutes of CT, while the EG received additional 40 minutes of VR therapy, five days a week for four weeks. Outcome measures included the Fugl-Meyer Assessment for Upper Extremity (FMA-UE), Selective Control of the Upper Extremity Scale (SCUES), Nine-Hole Peg Test (NHPT), Disabilities of the Arm, Shoulder and Hand questionnaire (DASH-T), and Stroke-Specific Quality of Life Scale (SS-QOL). Outcome assessments were performed by an independent assessor at baseline (T0), post-intervention (4 weeks,T1), and at 1 (T2)- and 3 (T3)-month follow-ups. We used the CONSORT (Consolidated Standards of Reporting Trials) reporting guideline to draft this manuscript and the CONSORT reporting checklist when editing, included in Table A1 Supplemental material. The parameters were compared between the control group and the experimental group across different time intervals in Table A2 Supplemental material. The parameters were compared within the control group and the experimental group in Table A3 Supplemental material.